IL7 and neoplasm: Autologous tumor cell vaccine loaded with NDV without IL-7 expression has shown promising results in clinical studies [37], but the superior antitumor efficacy of autologous vaccine loaded with IL-7-expressing NDV in preclinical studies suggests that IL-7 expression offers substantial therapeutic advantages.